^
Association details:
| Biomarker: | Chr t(3;9)(p13;q34) FOXP1/ABL1 |
|---|---|
| Cancer: | B Acute Lymphoblastic Leukemia |
| Drug: | imatinib (c-KIT inhibitor, Bcr-abl tyrosine kinase inhibitor, PDGFR inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
CASE REPORT: PH-LIKE ACUTE LYMPHIDE LEUKEMIA ASSOCIATED WITH T (3; 9) FOXP1-ABL1 IN YOUNG ADULT PATIENT
Published date:
11/26/2020
Excerpt:
Our case describes at (3.9) (p13; q34.1) FOXP1-ABL1 associated with ALL, being one of several translocations that fall under the LLA-B Ph-Like entity. The use of imatinib with chemotherapy may have contributed to the good therapeutic response so far, with negative DRM at the end of the induction.
DOI:
10.1016 / j.htct.2020.10.302
